Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
PRE-084
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H27NO3 |
Molar mass | 317.429 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
PRE-084 is a sigma receptor agonist, selective for the σ1 subtype. It has nootropic and antidepressant actions in animal studies, as well as antitussive and reinforcing effects. PRE-084 increases the expression of GDNF.
Synthesis
Sodium hydride mediated alkylation between Benzyl cyanide (1) and 1,5-dibromopentane [111-24-0] (2) gives 1-phenylcyclohexanecarbonitrile [2201-23-2] (3). Hydrolysis of the nitrile by treatment with aqueous potassium hydroxide in DEG gives 1-phenylcyclohexanecarboxylic acid [1135-67-7] (4). Halogenation with thionyl chloride gives 1-phenylcyclohexanecarbonyl chloride [2890-42-8]. This intermediate was not isolated but reacted with 2-morpholinoethanol [622-40-2] (5) to give the ester and hence, completing the synthesis of PRE084 (6).